Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 100/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03818620Active Not Recruiting

Research in the Development of a New Type of Digital Dermatoscope for Skin Cancer

Role: lead

NCT03497455Terminated

Utility of Digital Dermoscopy in the Skin Cancer Clinic

Role: lead

NCT04047316Completed

Development and Validation of a New Digital Dermatoscope in the United States

Role: lead

All 3 trials loaded